Cover Image
市場調查報告書

表現媒介市場預測 (∼2020年):各主型式 (細菌/大腸菌、哺乳類/CHO、昆蟲/桿狀病毒、酵母)、用途、終端用戶

Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020

出版商 MarketsandMarkets 商品編碼 333122
出版日期 內容資訊 英文 138 Pages
訂單完成後即時交付
價格
Back to Top
表現媒介市場預測 (∼2020年):各主型式 (細菌/大腸菌、哺乳類/CHO、昆蟲/桿狀病毒、酵母)、用途、終端用戶 Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020
出版日期: 2015年06月16日 內容資訊: 英文 138 Pages
簡介

表現媒介的市場預計從2015年到2020年以5.5%的年複合成長率推移,從2015年的2億4270萬美元到2020年成長到3億1710萬美元的規模。蛋白質為基礎的藥物 (生物製藥) 的需求擴大和文明病、感染疾病、遺傳性疾病的盛行率的增加,蛋白質研究的資金供給的擴大等,成為促進這個成長的主要原因。

本報告提供全球表現媒介的市場相關調查、表現媒介的概要與市場定義、各主型式、用途、終端用戶的市場分析及市場成長預測、地區及主要國家趨勢、競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場區隔
    • 各主型式
    • 各用途
    • 各終端用戶
    • 各地區
  • 市場動態
    • 推動因素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 各主型式市場

  • 簡介
  • 細菌表現媒介
    • 大腸菌表現媒介
    • 其他
  • 哺乳類表現媒介
    • CHO表現媒介
    • 其他
  • 昆蟲表現媒介
    • 桿狀病毒表現媒介
    • 其他
  • 酵母表現媒介
    • K. Lactis表現媒介
    • 畢赤酵母表現媒介
    • 出芽酵母表現媒介
    • 其他
  • 其他表現媒介

第7章 各用途市場

  • 簡介
  • 治療用
  • 產業用
  • 研究用

第8章 各終端用戶市場

  • 簡介
  • 醫藥品、生物科技企業
  • CROS、CMOS
  • 學術研究機關
  • 其他

第9章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞洲
  • 其他地區

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 聯盟、協定、合作
    • 擴張
    • 收購
    • 新產品的投入

第11章 企業簡介

  • Merck Millipore
  • Thermo Fisher Scientific, Inc.
  • Sigma-Aldrich Corporation
  • Promega Corporation
  • Clontech Laboratories, Inc.
  • Agilent Technologies
  • Bio-Rad Laboratories
  • DNA20., Inc.
  • New England Biolabs (NEB)
  • Qiagen
    • 概要
    • 財務趨勢
    • 產品與服務
    • 發展趨勢等

第12章 附錄

圖表

目錄
Product Code: BT 3493

The expression vectors market is expected to reach $317.1 million by 2020 from $242.7 million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. The market is categorized on the basis of host type, application, end user, and region. The application market includes therapeutic, research, and industrial applications. The therapeutic applications segment is expected to grow at the highest CAGR in the coming five years.

Major factors contributing to the growth of the global expression vectors market include increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. For instance, in September 2014, AbCelex Technologies Inc., a privately held Canadian biotechnology company, received a venture capital fund of $1 million by Pinetree Capital Corporation for development of the company's protein expression systems and antibody engineering techniques. Funding for protein research helps the expression vectors market to grow as it is an integral component of it.

The Asian expression vectors market is the fastest-growing market, globally. With huge man power and cost-effective manufacturing facilities, several market players are focusing on expanding their presence in the Asian countries. For instance, in November 2012, Promega Corporation (U.S.), a provider of expression vectors, opened a new facility in Shanghai, Shanghai Promega Life Science Center. This facility manufactures biological and chemical regents and instruments used in life science research and molecular diagnostics. Establishment of such facilities helps the local market with easy product availability and services.

Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the expression vectors market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the expression vectors market. The report analyzes this market by host type, application, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the expression vectors market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the expression vectors market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various expression vector products across regions
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the expression vectors market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Market Segmentation
    • 1.3.2. Years Considered for the Study
  • 1.4. Limitations
  • 1.5. Market Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Breakdown and Data Triangulation
  • 2.3. Key Data From Secondary Sources
  • 2.4. Key Data From Primary Sources
  • 2.5. Key Industry Insights
  • 2.6. Assumptions for the Study

3. Executive Summary

4. Premium Insights

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. By Host Type
    • 5.2.2. By Application
    • 5.2.3. By End User
    • 5.2.4. By Region
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Increase in Demand of Protein-Based Drugs (Biologics)
      • 5.3.1.2. High Prevalence Rate of Lifestyle Diseases, Infectious Diseases, and Genetic Disorders
      • 5.3.1.3. Funding for Protein Research
    • 5.3.2. Restraints
      • 5.3.2.1. High Market Consolidation Increases Entry Barriers and Restrains Market Growth
      • 5.3.2.2. High Cost of Protein Therapy
    • 5.3.3. Opportunities
      • 5.3.3.1. Developing Countries Present Significant Opportunities for Market
    • 5.3.4. Challenges
      • 5.3.4.1. Sequestration Cuts in the U.S.: Challenge to the North American Market

6. By Host Type

  • 6.1. Introduction
  • 6.2. Bacterial Expression Vectors
    • 6.2.1. E.Coli Expression Vectors
    • 6.2.2. Other Bacterial Expression Vectors
  • 6.3. Mammalian Expression Vectors
    • 6.3.1. CHO Expression Vectors
    • 6.3.2. Other Mammalian Expression Vectors
  • 6.4. Insect Expression Vectors
    • 6.4.1. Baculovirus Expression Vectors
    • 6.4.2. Other Insect Expression Vectors
  • 6.5. Yeast Expression Vectors
    • 6.5.1. K. Lactis Expression Vectors
    • 6.5.2. Pichia Pastoris Expression Vectors
    • 6.5.3. Saccharomyces Cerevisiae Expression Vectors
    • 6.5.4. Other Yeast Expression Vectors
  • 6.6. Other Expression Vectors

7. By Application

  • 7.1. Introduction
  • 7.2. Therapeutic Applications
  • 7.3. Industrial Applications
  • 7.4. Research Applications

8. By End User

  • 8.1. Introduction
  • 8.2. Pharmaceutical and Biotechnology Companies
  • 8.3. CROS and CMOS
  • 8.4. Academic Research Institutes
  • 8.5. Other End Users

9. Geographic Analysis

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
  • 9.4. Asia
  • 9.5. Rest of the World (RoW)

10. Competitive Landscape

  • 10.1. Overview
  • 10.2. Market Share Analysis, By Key Players, 2014
  • 10.3. Competitive Situation and Trends
    • 10.3.1. Partnerships, Agreements, and Collaborations
    • 10.3.2. Expansions
    • 10.3.3. Acquisitions
    • 10.3.4. New Product Launches

11. Company Profiles (Overview, Financials, Products, & Developments)*

  • 11.1. Merck Millipore
  • 11.2. Thermo Fisher Scientific, Inc.
  • 11.3. Sigma-Aldrich Corporation
  • 11.4. Promega Corporation
  • 11.5. Clontech Laboratories, Inc.
  • 11.6. Agilent Technologies
  • 11.7. Bio-Rad Laboratories
  • 11.8. DNA20., Inc.
  • 11.9. New England Biolabs (NEB)
  • 11.10. Qiagen

12. Appendix

  • 12.1. Insights From Industry Experts
  • 12.2. Discussion Guide
  • 12.3. Introducing RT: Real-Time Market Intelligence
  • 12.4. Available Customizations
  • 12.5. Related Reports

List of Tables

  • Table 1: The Global Market Size, By Host Type, 2013-2020 ($Million)
  • Table 2: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 3: Bacterial Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 4: North America: Bacterial Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 5: E.Coli Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 6: North America: E.Coli Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 7: Other Bacterial Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 8: North America: Other Bacterial Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 9: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 10: Mammalian Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 11: North America: Mammalian Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 12: CHO Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 13: North America: CHO Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 14: Other Mammalian Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 15: North America: Other Mammalian Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 16: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 17: Insect Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 18: North America: Insect Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 19: Baculovirus Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 20: North America: Baculovirus Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 21: Other Insect Expression Vectors Market Size, By Region, 2013-2020 ($Thousand)
  • Table 22: North America: Other Insect Expression Vectors Market Size, By Country, 2013-2020 ($Thousand)
  • Table 23: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 24: Yeast Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 25: North America: Yeast Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 26: K. Lactis Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 27: North America: K. Lactis Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 28: P. Pastoris Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 29: North America: P. Pastoris Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 30: S. Cerevisiae Expression Vectors Market Size, By Region, 2013-2020 ($Million)
  • Table 31: North America: S. Cerevisiae Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 32: Other Yeast Expression Vectors, By Region, 2013-2020 ($Thousand)
  • Table 33: North America: Market Size for Other Yeast Systems, By Country, 2013-2020 ($Thousand)
  • Table 34: Other Market Size, By Region, 2013-2020 ($Million)
  • Table 35: North America: Other Expression Vectors Market Size, By Country, 2013-2020 ($Million)
  • Table 36: Market Size, By Application, 2013-2020 ($Million)
  • Table 37: Market Size for Therapeutic Applications, By Region, 2013-2020 ($Million)
  • Table 38: North America: Market Size for Therapeutic Applications, By Country, 2013-2020 ($Million)
  • Table 39: Market Size for Research Applications, By Region, 2013-2020 ($Million)
  • Table 40: North America: Market Size for Research Applications, By Country, 2013-2020 ($Million)
  • Table 41: Market Size for Industrial Applications, By Region, 2013-2020 ($Million)
  • Table 42: North America: Market Size for Industrial Applications, By Country, 2013-2020 ($Million)
  • Table 43: Market Size, By End User, 2013-2020 ($Million)
  • Table 44: Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013-2020 ($Million)
  • Table 45: North America: Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013-2020 ($Million)
  • Table 46: Market Size for CROS and CMOS, By Region, 2013-2020 ($Million)
  • Table 47: North America: Market Size for CROS and CMOS, By Country, 2013-2020 ($Million)
  • Table 48: Market Size for Academic Research Institutes, By Region, 2013-2020 ($Million)
  • Table 49: North America: Market Size for Academic Research Institutes, By Country, 2013-2020 ($Million)
  • Table 50: Market Size for Other End Users, By Region, 2013-2020 ($Million)
  • Table 51: North America: Market Size for Other End Users, By Country, 2013-2020 ($Million)
  • Table 52: Market Size, By Region, 2013-2020 ($Million)
  • Table 53: North America: Market Size, By Country, 2013-2020 ($Million)
  • Table 54: North America: Market Size, By Host Type, 2013-2020 ($Million)
  • Table 55: North America: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 56: North America: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 57: North America: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 58: North America: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 59: North America: Market Size, By Application, 2013-2020 ($Million)
  • Table 60: North America: Market Size, End User, 2013-2020 ($Million)
  • Table 61: U.S.: Market Size, By Host Type, 2013-2020 ($Million)
  • Table 62: U.S.: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 63: U.S.: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 64: U.S.: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 65: U.S.: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 66: U.S.: Market Size, By Application, 2013-2020 ($Million)
  • Table 67: U.S.: Market Size, By End User, 2013-2020 ($Million)
  • Table 68: Canada: Market Size, By Host Type, 2013-2020 ($Million)
  • Table 69: Canada: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 70: Canada: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 71: Canada: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 72: Canada: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 73: Canada: Market Size, By Application, 2013-2020 ($Million)
  • Table 74: Canada: Market Size, By End User, 2013-2020 ($Million)
  • Table 75: Europe: Market Size, By Host Type, 2013-2020 ($Million)
  • Table 76: Europe: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 77: Europe: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 78: Europe: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 79: Europe: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 80: Europe: Market Size, By Application, 2013-2020 ($Million)
  • Table 81: Europe: Market Size, By End User, 2013-2020 ($Million)
  • Table 82: Asia: Market Size, By Host Type, 2013-2020 ($Million)
  • Table 83: Asia: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 84: Asia: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 85: Asia: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 86: Asia: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 87: Asia: Market Size, By Application, 2013-2020 ($Million)
  • Table 88: Asia: Market Size, By End User, 2013-2020 ($Million)
  • Table 89: RoW: Market Size, By Host Type, 2013-2020 ($Million)
  • Table 90: RoW: Bacterial Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 91: RoW: Mammalian Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 92: RoW: Yeast Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 93: RoW: Insect Expression Vectors Market Size, By Type, 2013-2020 ($Million)
  • Table 94: RoW: Market Size, By Application, 2013-2020 ($Million)
  • Table 95: RoW: Market Size, By End User, 2013-2020 ($Million)
  • Table 96: Parterships, Agreements and Collaborations, 2012-2015
  • Table 97: Expansions, 2012-2015
  • Table 98: Acquisitions, 2012-2015
  • Table 99: New Product Launches, 2012-2015

List of Figures

  • Figure 1: Research Design
  • Figure 2: Market Size Estimation: Bottom-Up Approach
  • Figure 3: Market Size Estimation: Top-Down Approach
  • Figure 4: Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 5: Data Triangulation Methodology
  • Figure 6: Market Snapshot, By Host Type (2015 vs. 2020)
  • Figure 7: CROS and CMOS Form the Fastest-Growing End-User Segment
  • Figure 8: Market, By Application (2015-2020): Therapeutic Applications to Witness Highest Growth
  • Figure 9: Global Market, By Region: North America Expected to Hold the Largest Share in 2015
  • Figure 10: Mammalian Expression Vectors Market to Grow at the Highest CAGR From 2015 to 2020
  • Figure 11: Therapeutic Applications Segment to Witness Highest Growth Rate in the Forecast Period
  • Figure 12: Pharmaceutical and Biotechnology Companies Command the Largest Share in 2015
  • Figure 13: Asia to Witness Highest Growth in the Forecast Period
  • Figure 14: Bacterial, Mammalian, and Insect Expression Vectors : Major Market Segments in 2015
  • Figure 15: Market Segmentation: By Host Type
  • Figure 16: Market Segmentation: By Application
  • Figure 17: Market Segmentation: By End User
  • Figure 18: Market Segmentation: By Region
  • Figure 19: Increase in Demand of Protein-Based Drugs to Propel the Market Growth
  • Figure 20: Mammalian Expression Vectors to Witness Significant Growth in the Forecast Period
  • Figure 21: Bacterial Expression Vectors to Dominate Expression Vectors Market in 2015
  • Figure 22: K. Lactis Expression Vectors to Witness Highest Growth
  • Figure 23: Therapeutic Applications: Fastest-Growing Application Segment
  • Figure 24: Therapeutic Applications: Asia to Show Highest Growth
  • Figure 25: End-User Base: Market
  • Figure 26: CROS and CMOS, A High-Growth End-User Segment in the Market
  • Figure 27: Asia- an Attractive Destination for All Applications
  • Figure 28: North America Holds the Largest Share of Global Market (2015)
  • Figure 29: European Market Snapshot
  • Figure 30: Asian Market to Grow at Highest CAGR
  • Figure 31: RoW Market Snapshot
  • Figure 32: Major Players Adopted Inorganic Growth Strategies for Development
  • Figure 33: Global Market Share Analysis, By Key Player, 2014.
  • Figure 34: Market Evolution Framework: Partnerships, Agreements and Collaborations and Expansions Fuelled the Market Growth
  • Figure 35: Battle for Market Share: Partnerships, Agreements and Collaborations Were the Key Strategies
  • Figure 36: Merck Millipore: Company Snapshot
  • Figure 37: Thermo Fisher Scientific, Inc.: Company Snapshot
  • Figure 38: Sigma-Aldrich Corporation: Company Snapshot
  • Figure 39: Promega Corporation: Company Snapshot
  • Figure 40: Takara Bio, Inc.: Company Snapshot
  • Figure 41: Agilent Technologies: Company Snapshot
  • Figure 42: Bio-Rad Laboratories: Company Snapshot
  • Figure 43: DNA2.0, Inc.: Company Snapshot
  • Figure 44: New England Biolabs: Company Snapshot
  • Figure 45: Qiagen: Company Snapshot
Back to Top